Alkermes plc Peer Comparison
Metric | Value | Ranking | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $5.0 Billion | 4/15 | ITCI $14.0B |
NBIX $11.5B |
RDY $11.2B |
ALKS $5.0B |
PBH $4.3B |
DCPH $2.2B |
ANIP $1.4B |
PCRX $1.2B |
AMPH $1.1B |
DVAX $1.1B |
COLL $928.3M |
PAHC $907.7M |
EOLS $631.9M |
IRWD $244.8M |
EGRX $20.1M |
Gross Margin | 86% | 6/15 | IRWD 100% |
ANIP 100% |
NBIX 99% |
DCPH 92% |
ITCI 90% |
ALKS 86% |
PCRX 79% |
EGRX 74% |
EOLS 64% |
RDY 59% |
PBH 55% |
COLL 54% |
AMPH 46% |
PAHC 33% |
DVAX 0% |
Profit Margin | 34% | 1/15 | ALKS 34% |
IRWD 34% |
PBH 21% |
AMPH 20% |
RDY 17% |
NBIX 16% |
PCRX 9% |
EGRX 8% |
COLL 7% |
PAHC 1% |
DVAX 0% |
ANIP -5% |
ITCI -8% |
EOLS -9% |
DCPH -100% |
EBITDA margin | 42% | 1/15 | ALKS 42% |
AMPH 35% |
PBH 33% |
RDY 29% |
IRWD 28% |
PCRX 27% |
NBIX 24% |
COLL 21% |
EGRX 17% |
ANIP 8% |
PAHC 8% |
EOLS -13% |
ITCI -15% |
DVAX -100% |
DCPH -105% |
Quarterly Revenue | $430.0 Million | 3/15 | RDY $1.0B |
NBIX $627.7M |
ALKS $430.0M |
PAHC $309.3M |
PBH $290.3M |
ITCI $199.2M |
ANIP $190.6M |
PCRX $187.3M |
AMPH $187.0M |
COLL $181.9M |
IRWD $91.6M |
EOLS $78.9M |
EGRX $64.6M |
DCPH $45.0M |
DVAX $0 |
Quarterly Earnings | $146.5 Million | 2/15 | RDY $171.1M |
ALKS $146.5M |
NBIX $103.1M |
PBH $61.0M |
AMPH $38.0M |
IRWD $31.1M |
PCRX $16.0M |
COLL $12.5M |
EGRX $5.2M |
PAHC $3.2M |
DVAX -$0 |
EOLS -$6.8M |
ANIP -$10.3M |
ITCI -$16.9M |
DCPH -$45.1M |
Quarterly Free Cash Flow | $180.6 Million | 2/15 | NBIX $235.2M |
ALKS $180.6M |
COLL $84.1M |
PBH $63.5M |
PCRX $31.0M |
AMPH $16.6M |
ANIP $13.4M |
EOLS $3.4M |
DVAX -$0 |
IRWD -$0 |
EGRX -$132,000 |
PAHC -$4.7M |
ITCI -$12.7M |
RDY -$26.6M |
DCPH -$54.7M |
Trailing 4 Quarters Revenue | $1.6 Billion | 3/15 | RDY $2.9B |
NBIX $2.4B |
ALKS $1.6B |
PBH $1.1B |
PAHC $1.1B |
AMPH $730.0M |
PCRX $701.0M |
ITCI $680.6M |
COLL $631.4M |
ANIP $614.4M |
IRWD $378.4M |
EOLS $265.4M |
EGRX $257.6M |
DVAX $203.9M |
DCPH $174.9M |
Trailing 4 Quarters Earnings | $367.1 Million | 2/15 | RDY $1.0B |
NBIX $627.7M |
ALKS $430.0M |
PAHC $309.3M |
PBH $290.3M |
ITCI $199.2M |
ANIP $190.6M |
PCRX $187.3M |
AMPH $187.0M |
COLL $181.9M |
IRWD $91.6M |
EOLS $78.9M |
EGRX $64.6M |
DCPH $45.0M |
DVAX -$0 |
Quarterly Earnings Growth | -9% | 10/15 | EGRX 155% |
PAHC 150% |
IRWD 103% |
EOLS 43% |
ITCI 41% |
PBH 15% |
AMPH 5% |
RDY 2% |
DCPH 2% |
ALKS -9% |
NBIX -30% |
PCRX -36% |
COLL -61% |
DVAX -100% |
ANIP -990% |
Annual Earnings Growth | 21% | 4/15 | PAHC 185% |
IRWD 103% |
ITCI 26% |
ALKS 21% |
EOLS 19% |
PBH 0% |
DCPH -4% |
AMPH -13% |
NBIX -14% |
COLL -26% |
RDY -30% |
DVAX -57% |
EGRX -87% |
ANIP -160% |
PCRX -273% |
Quarterly Revenue Growth | 14% | 10/15 | ITCI 51% |
ANIP 45% |
DCPH 35% |
EOLS 33% |
PAHC 24% |
NBIX 22% |
COLL 22% |
AMPH 20% |
RDY 16% |
ALKS 14% |
PBH 3% |
PCRX 3% |
EGRX -13% |
IRWD -19% |
DVAX -100% |
Annual Revenue Growth | 2% | 10/15 | ITCI 34% |
EOLS 28% |
DCPH 23% |
NBIX 17% |
ANIP 17% |
PAHC 17% |
COLL 13% |
AMPH 5% |
PCRX 4% |
ALKS 2% |
PBH -2% |
IRWD -13% |
RDY -14% |
DVAX -23% |
EGRX -39% |
Cash On Hand | $291.1 Million | 2/15 | ITCI $306.9M |
ALKS $291.1M |
PCRX $276.8M |
NBIX $233.0M |
AMPH $151.6M |
RDY $148.8M |
ANIP $144.9M |
DVAX $95.9M |
DCPH $91.2M |
IRWD $88.2M |
EOLS $87.0M |
COLL $70.6M |
PAHC $67.1M |
PBH $50.9M |
EGRX $15.4M |
Short Term Debt | $6.2 Million | 7/15 | RDY $526.8M |
PCRX $210.7M |
ANIP $9.2M |
EGRX $8.3M |
AMPH $7.0M |
PBH $6.9M |
ALKS $6.2M |
ITCI $4.2M |
DVAX $4.2M |
DCPH $3.6M |
IRWD $3.2M |
COLL $1.3M |
NBIX -$0 |
PAHC -$0 |
EOLS -$0 |
Long Term Debt | $69.4 Million | 10/15 | AMPH $643.5M |
PAHC $622.9M |
NBIX $455.1M |
PCRX $428.2M |
ANIP $305.8M |
DVAX $250.2M |
COLL $242.7M |
IRWD $211.7M |
RDY $91.8M |
ALKS $69.4M |
EGRX $61.9M |
PBH $56.5M |
DCPH $21.4M |
ITCI $12.7M |
EOLS $0 |
PE | 13.54 | 6/15 | DVAX 55.78 |
PAHC 46.99 |
NBIX 33.55 |
RDY 22.71 |
PBH 20.21 |
ALKS 13.54 |
COLL 13.42 |
AMPH 7.18 |
IRWD 2.77 |
EGRX 1.29 |
PCRX -1.00 |
ITCI -1.00 |
ANIP -1.00 |
DCPH -1.00 |
EOLS -1.00 |
PS | 3.19 | 7/15 | RDY 316.66 |
ITCI 20.64 |
DCPH 12.65 |
DVAX 5.54 |
NBIX 4.86 |
PBH 3.87 |
ALKS 3.19 |
EOLS 2.38 |
ANIP 2.33 |
PCRX 1.66 |
AMPH 1.57 |
COLL 1.47 |
PAHC 0.82 |
IRWD 0.65 |
EGRX 0.08 |
PB | 3.39 | 6/15 | EOLS 114.43 |
ITCI 12.23 |
DCPH 7.00 |
NBIX 4.42 |
PAHC 3.68 |
ALKS 3.39 |
ANIP 3.34 |
RDY 2.87 |
PBH 2.42 |
IRWD 1.91 |
DVAX 1.89 |
AMPH 1.56 |
PCRX 1.49 |
COLL 0.66 |
EGRX 0.08 |
PC | 17.07 | 6/15 | PBH 85.01 |
RDY 75.03 |
NBIX 49.15 |
ITCI 45.76 |
DCPH 24.26 |
ALKS 17.07 |
PAHC 13.53 |
COLL 13.16 |
DVAX 11.78 |
ANIP 9.87 |
AMPH 7.55 |
EOLS 7.27 |
PCRX 4.20 |
IRWD 2.78 |
EGRX 1.31 |
Liabilities to Equity | 0.40 | 12/15 | EOLS 41.12 |
PAHC 4.21 |
IRWD 2.03 |
ANIP 2.00 |
AMPH 1.15 |
PCRX 1.00 |
PBH 0.86 |
DVAX 0.65 |
EGRX 0.61 |
RDY 0.50 |
NBIX 0.44 |
ALKS 0.40 |
DCPH 0.33 |
ITCI 0.19 |
COLL 0.15 |
ROA | 0.18 | 2/15 | IRWD 23% | ALKS 18% | AMPH 10% | NBIX 9% | PBH 6% | COLL 4% | EGRX 4% | DVAX 2% | PAHC 2% | RDY 0% | ANIP -1% | ITCI -5% | PCRX -6% | EOLS -22% | DCPH -45% |
ROE | 0.25 | 2/15 | IRWD 69% |
ALKS 25% |
AMPH 22% |
NBIX 13% |
PBH 12% |
PAHC 8% |
EGRX 6% |
COLL 4% |
DVAX 3% |
RDY 0% |
ANIP -4% |
ITCI -7% |
PCRX -13% |
DCPH -60% |
EOLS -913% |
Current Ratio | 3.48 | 4/15 | COLL 6.73 |
ITCI 6.26 |
DCPH 4.01 |
ALKS 3.48 |
NBIX 3.29 |
RDY 3.02 |
EGRX 2.65 |
DVAX 2.53 |
PBH 2.16 |
PCRX 2.00 |
AMPH 1.87 |
ANIP 1.50 |
IRWD 1.49 |
PAHC 1.24 |
EOLS 1.02 |
Quick Ratio | 1.27 | 4/15 | DVAX 55.78 |
PAHC 46.99 |
NBIX 33.55 |
RDY 22.71 |
PBH 20.21 |
ALKS 13.54 |
COLL 13.42 |
AMPH 7.18 |
IRWD 2.77 |
EGRX 1.29 |
PCRX -1.00 |
ITCI -1.00 |
ANIP -1.00 |
DCPH -1.00 |
EOLS -1.00 |
Long Term Debt to Equity | 0.05 | 11/15 | PAHC} 2.52 |
IRWD} 1.65 |
AMPH} 0.88 |
ANIP} 0.71 |
PCRX} 0.55 |
DVAX} 0.42 |
EGRX} 0.25 |
NBIX} 0.18 |
COLL} 0.15 |
DCPH} 0.07 |
ALKS} 0.05 |
PBH} 0.03 |
RDY} 0.02 |
ITCI} 0.01 |
EOLS} 0.00 |
Debt to Equity | 0.05 | 13/15 | EOLS 23.54 |
PAHC 2.52 |
IRWD 1.67 |
AMPH 0.89 |
PCRX 0.82 |
ANIP 0.74 |
DVAX 0.43 |
EGRX 0.28 |
NBIX 0.18 |
RDY 0.16 |
COLL 0.14 |
DCPH 0.08 |
ALKS 0.05 |
PBH 0.02 |
ITCI 0.01 |
Burn Rate | -2.05 | 10/15 | ITCI 16.63 |
EOLS 12.80 |
ANIP 5.84 |
PCRX 5.15 |
PAHC 3.09 |
DCPH 1.95 |
RDY 1.12 |
PBH -0.89 |
DVAX -1.00 |
ALKS -2.05 |
NBIX -2.74 |
IRWD -4.04 |
AMPH -14.49 |
EGRX -25.01 |
COLL -28.12 |
Cash to Cap | 0.06 | 10/15 | EGRX 0.76 |
IRWD 0.36 |
PCRX 0.24 |
EOLS 0.14 |
AMPH 0.13 |
ANIP 0.10 |
DVAX 0.08 |
COLL 0.08 |
PAHC 0.07 |
ALKS 0.06 |
DCPH 0.04 |
NBIX 0.02 |
ITCI 0.02 |
PBH 0.01 |
RDY 0.01 |
CCR | 1.23 | 4/15 | COLL 6.71 |
NBIX 2.28 |
PCRX 1.93 |
ALKS 1.23 |
DCPH 1.21 |
PBH 1.04 |
ITCI 0.75 |
AMPH 0.44 |
IRWD 0.00 |
EGRX -0.03 |
RDY -0.16 |
EOLS -0.51 |
ANIP -1.30 |
PAHC -1.49 |
DVAX |
EV to EBITDA | 26.20 | 7/15 | ANIP} 107.76 |
NBIX} 76.75 |
PAHC} 57.22 |
PBH} 44.62 |
PCRX} 30.13 |
COLL} 28.73 |
ALKS} 26.20 |
AMPH} 25.28 |
IRWD} 14.49 |
EGRX} 6.97 |
RDY} 1.60 |
DVAX} -1.00 |
DCPH} -45.43 |
EOLS} -66.07 |
ITCI} -472.95 |
EV to Revenue | 3.05 | 6/15 | ITCI 20.21 |
RDY 13.37 |
DCPH 12.27 |
NBIX 4.96 |
PBH 3.85 |
ALKS 3.05 |
ANIP 2.61 |
EOLS 2.54 |
AMPH 2.25 |
PCRX 2.18 |
COLL 1.73 |
PAHC 1.32 |
IRWD 0.98 |
EGRX 0.29 |
DVAX -1.00 |